Laser Therapy Combined With Intravitreal Aflibercept vs Intravitreal Aflibercept Monotherapy (LADAMO)

计划入组 48 人 · 首次发布于 2015 年 5 月 4 日

Aflibercept Plus Micropulse Laser Versus Aflibercept Monotherapy for Diabetic Macular Edema

计划入组 40 人 · 首次发布于 2019 年 7 月 10 日

DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME

计划入组 270 人 · 首次发布于 2017 年 10 月 25 日

Aflibercept(Eylea, Zaltrap, Yesafili, Eydenzelt, Ahzantive, Afqlir, Baiama, Opuviz, Pavblu, Mynzepli, Vgenfli, Eiyzey)

Rx

Aflibercept-mrbb

aflibercept bioslimilar

Gimon Yoav

Israel

BOAN BIOTECH

China

BOA BIOMEDICAL, INC.

United States

Celltrion Receives FDA Approval for EYDENZELT, First Aflibercept Biosimilar for Retinal Diseases

CHMP Issues Positive Opinion for Formycon's Aflibercept Biosimilar FYB203

FDA Approves Pavblu, Fifth Biosimilar to Eylea, for Retinal Conditions